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BACKGROUND: Ambient air pollution and tuberculosis (TB) have an impact on public health worldwide, yet associations between the two remain
uncertain.
OBJECTIVE:We determined the impact of residential traffic on mortality during treatment of active TB.
METHODS: From 2000–2012, we enrolled 32,875 patients in California with active TB and followed them throughout treatment. We obtained patient
data from the California Tuberculosis Registry and calculated traffic volumes and traffic densities in 100- to 400-m radius buffers around residential
addresses. We used Cox models to determine mortality hazard ratios, controlling for demographic, socioeconomic, and clinical potential confounders.
We categorized traffic exposures as quintiles and determined trends using Wald tests.
RESULTS: Participants contributed 22,576 person-years at risk. There were 2,305 deaths during treatment for a crude mortality rate of 1,021 deaths
per 10,000 person-years. Traffic volumes and traffic densities in all buffers around patient residences were associated with increased mortality during
TB treatment, although the findings were not statistically significant in all buffers. As the buffer size decreased, fifth-quintile mortality hazards
increased, and trends across quintiles of traffic exposure became more statistically significant. Increasing quintiles of nearest-road traffic volumes in
the 100-m buffer were associated with 3%, 14%, 19%, and 28% increased risk of death during TB treatment [first quintile, referent; second quintile
hazard ratio ðHRÞ=1:03 [95% confidence interval (CI): 0.86, 1.25]; third quintile HR=1:14 (95% CI: 0.95, 1.37); fourth quintile HR=1:19 (95% CI:
0.99, 1.43); fifth quintile HR=1:28 (95% CI: 1.07, 1.53), respectively; p-trend= 0:002].
CONCLUSIONS: Residential proximity to road traffic volumes and traffic density were associated with increased all-cause mortality in patients under-
going treatment for active tuberculosis even after adjusting for multiple demographic, socioeconomic, and clinical factors, suggesting that TB patients
are susceptible to the adverse health effects of traffic-related air pollution. https://doi.org/10.1289/EHP1699
Introduction
Tuberculosis (TB) has an impact on health worldwide, with an
estimated 9.6 million people developing active TB and 1.5 mil-
lion people dying from the disease in 2014 (WHO 2015). TB
mortality rates remain high despite adequate treatment (Fielder
et al. 2002; Pascopella et al. 2014), and the effects of environ-
mental factors such as ambient air pollution on TB outcomes
remain uncertain. The majority of the world’s population is
exposed to unhealthy levels of ambient air pollution, with
approximately 89% living in areas where fine particulate mat-
ter <2:5 lm in diameter (PM2:5) exceeds World Health
Organization (WHO) air quality standards (Brauer et al. 2012),
and it is estimated that ambient air pollution contributes to
approximately 3.3 million premature deaths each year (Lelieveld
et al. 2015).
It has long been observed that certain inhaled toxicants are
associated with pulmonary infection: Published studies as far
back as 100 y ago reported associations between tobacco smok-
ing and TB (Webb 1918). There is now ample evidence to sug-
gest that active tobacco smokers are at increased risk for TB
infection, progression to active TB, and worse treatment out-
comes including mortality (Bates et al. 2007; Horne et al. 2012;
Jee et al. 2009; Lin et al. 2007; Maciel et al. 2013; Slama et al.
2007). This evidence has led the WHO to affirm tobacco smoking
as a significant TB risk factor (WHO 2016).
Tobacco smoke is composed of a number of chemical com-
pounds that are also found in traffic emissions (CDC 2010;
Gentner et al. 2013; Karjalainen et al. 2014), raising concerns
that traffic-related air pollution (TRAP) could also be associated
with adverse TB outcomes. Ambient air pollution is an estab-
lished risk factor for community-acquired pneumonia (Chiu et al.
2009; Neupane et al. 2010; Zanobetti et al. 2000), yet studies
linking ambient air pollution to other pulmonary infections such
as TB are limited. The effects of ambient air pollution on TB inci-
dence have been investigated in a few studies with mixed find-
ings. In a nested case–control study using a northern California
managed-care database, nitrogen dioxide (NO2) was associated
with increased odds of active TB (Smith et al. 2016); in a
community-based cohort study in Taipei, Taiwan, both PM2:5
and NO2 were associated with increased risk of active TB (Lai
et al. 2016); and in Beijing and Hong Kong, China, outdoor
PM2:5 was associated with seasonal changes in TB incidence
(You et al. 2016). However, in a time-series study in Seoul,
South Korea, spikes in sulfur dioxide (SO2) but not in particulate
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matter <10 lm in diameter (PM10), NO2, or ozone were associ-
ated with temporally related increases in TB incidence (Hwang
et al. 2014). The effects of ambient air pollution on TB treatment
outcomes remain uncertain, and there has been only one pub-
lished study to date that has examined the association of ambient
air pollution with mortality during TB treatment; this study found
that annual mean estimates of PM2:5 were associated with
increased mortality (Peng et al. 2017). Additionally, there has
been only one published study to evaluate traffic proximity as a
TB risk factor. This study did not find a statistically significant
association between distance to the nearest major road or freeway
and smear positivity among patients with pulmonary TB in Los
Angeles, California (Jassal et al. 2013). However, the study’s
small sample size and cross-sectional design preclude firm con-
clusions linking these traffic metrics to TB outcomes, thereby
warranting a larger study with a prospective cohort study design
from which causal inferences can be made.
We used proximity to road traffic volumes and proximity to
traffic density as measures of traffic-related air pollution instead
of individual air pollutant models because our traffic proximity
models capture the mix of pollutants emitted from motor vehicles
as opposed to models for individual pollutants that might provide
a less-complete representation of traffic exposure. For instance,
in a study evaluating the association of traffic exposures with
childhood incident asthma, the effect of NO2 on incident asthma,
which had a hazard ratio (HR) of 2.17 [95% confidence interval
(CI): 1.18, 4.00], was attenuated to 1.37 (95% CI: 0.69, 2.71)
when adjusting for traffic exposure using a line source dispersion
model that included distance to roadways and vehicle counts
(McConnell et al. 2010), suggesting that traffic proximity was a
key factor for determining TRAP health effects. Furthermore, in
another study comparing different TRAP exposure metrics, traffic
density was found to be “reasonably consistent with the more so-
phisticated metrics” (Batterman et al. 2014).
Both TB and ambient air pollution are significant public
health issues in California. Nearly 25% of all U.S. TB cases occur
in California (Salinas et al. 2016), and >80% of Californians live
in counties with unhealthy ambient air concentrations of PM2:5,
ozone, or both (ALA 2016). Additionally, the predominant
source of air pollution in California is from traffic emissions
(ARB 2017). We hypothesized that proximity to road traffic vol-
umes and traffic density would be associated with increased mor-
tality in patients undergoing TB treatment and that the effects
would be mediated through clinical markers of TB severity. To
test these hypotheses, we designed and implemented a large
cohort study of TB patients reported to the State of California
and followed longitudinally by California Department of Public
Health TB clinics throughout their TB treatment.
Methods
Study Cohort
All reported pediatric and adult TB cases in California between 1
January 2000 and 31 December 2012 were eligible for inclusion.
A TB case was specified as a person of any age with clinically
diagnosed or microbiologically confirmed (or both) active TB as
defined by the Centers for Disease Control and Prevention
(CDC). Clinical diagnostic criteria included symptoms, physical
exam, and radiographic findings consistent with TB along with
an appropriate response to treatment. Acceptable microbiologic
confirmation included culture or nucleic acid amplification test-
ing (or both) positive for Mycobacterium tuberculosis (Mtb).
Patients were excluded from survival analyses if traffic data were
unavailable at residential addresses, if residential addresses were
either not available or not geocodable to street-level resolution, if
patients died or moved out of California before treatment was ini-
tiated, or if treatment dates were unavailable.
Traffic Exposure Assessment
Residential street addresses were obtained at the time of TB diag-
nosis and were later transformed into geocoded coordinates using
browser-based geocoding software developed by the California
Environmental Health Tracking Program (CEHTP) at the
California Department of Public Health (CDPH). This software
matched addresses to geographic coordinates using Tele Atlas®
(TomTom Telematics), Navteq® (Nokia Here), and TIGER® (U.S.
Census Bureau) reference data sets for 2010 and 2011. For home-
less patients, we used the shelter address or the street intersection
of the patient’s most recent sleeping location. Geocoding accuracy
was quantified using a score based on how well the input address
text elements matched the same elements of the geocoding refer-
ence database. The score ranged from 0 to 100, with 100 repre-
senting an exact match.
Traffic data from 2004 were obtained from the California
Department of Transportation (Caltrans) Highway Performance
Monitoring System, with data available for roads functionally
classified as collectors, arterials, freeways, expressways, and
interstates, collectively referred to as “major” roads in this study.
Traffic data were not available for small local roads. Because the
distance from traffic source for maximum health impact was
uncertain (Puett et al. 2014), we calculated traffic exposures
within four circular zones (buffers) of radius 100–400 m around
each participant’s residential address using CEHTP Traffic
Spatial Linkage Service software (CDPH). Within each of these
buffers, we evaluated traffic volume [average number of vehicles
(vh) traversing a road segment per 24 h] at the nearest major road
and at the highest-trafficked road, and traffic density was calcu-
lated as the sum of length-adjusted major road segment traffic
counts within each buffer per hour (vehicle·kilometers/hour). We
selected these traffic indicators to best characterize distance to ex-
posure source as well as peak and overall exposure concentra-
tions. Left-censored traffic data due to the absence of major roads
in a buffer were considered missing.
Outcome Assessment
Patients were followed longitudinally throughout TB treatment
by one of 61 local health department TB programs. Baseline and
follow-up demographic, socioeconomic, and clinical data were
recorded by trained local health officials into the Report of
Verified Case of Tuberculosis (RVCT), a CDC-developed data
collection tool. RVCT data were then entered into a CDPH cen-
tral data repository (the California TB Registry). Our preselected
primary outcome was all-cause mortality during active TB treat-
ment. Follow-up time began on the first day of TB treatment and
ended on the date of death (event) or was right-censored on the
date of adequate completion of TB therapy, cessation of therapy
for other reasons, moving out of state, loss to follow-up, or the
end of the study, whichever occurred first.
Ethics Approval
The study was approved by the institutional review boards at the
University of California, San Francisco and the California Health
and Human Services Agency Committee for the Protection of
Human Subjects. Informed consent was not required because the
study relied on existing public health records rather than on direct
patient contact, and all personal identifiers were removed from
the database before analysis.
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Statistical analysis
We fit Cox proportional hazards models to determine HRs for
mortality during TB treatment predicted by each traffic metric in
100-to 400-m buffers around residential addresses. We trans-
formed traffic volumes and traffic density into quintiles to better
adhere to log-linearity of hazard function assumptions, and we
tested for linear trends across quintiles using Wald tests
(Vittinghoff et al. 2012), reporting calculated p-values as p-
trends. Traffic exposure associations with mortality were consid-
ered statistically significant for p-trends <0:05 in at least two of
the four buffers tested. In forming quintiles, we chose exposure
cut points that would split participants into five equal groups.
Individual-level demographic, socioeconomic, and clinical cova-
riates were selected a priori as potential confounders and were
included in the final multivariable models if associated with mor-
tality in univariate Cox models with a p-value <0:2. In alterna-
tive models, we additionally adjusted for two group-level
variables: census block group median annual household income
from the 2006–2010 American Community Survey (U.S. Census
Bureau 2016) and census-tract tobacco smoking prevalence esti-
mates (Ortega Hinojosa et al. 2014). We tested for effect modifi-
cation by defining interaction terms between traffic density and
each of the following: age, sex, race, ethnicity, region of resi-
dence, enrollment year, bacteriologic confirmation, directly
observed TB treatment (DOT), census-tract tobacco smoking
estimates, and HIV; we fitted separate multivariable Cox models
with each of these interaction terms and reported effect modifica-
tion for a p-interaction ≤0:05 in at least one buffer and a consist-
ent pattern of effect modification in all buffers. We performed
mediation analyses to determine if the effects of traffic on mortal-
ity were mediated through TB severity, and we performed multi-
ple sensitivity analyses to test the robustness of our findings
across alternative Cox models. Standard diagnostics and assump-
tion checks were performed on all models. Time-varying covari-
ate models were not employed; instead, covariates with time
dependency were assigned fixed measurement times and values.
The comorbidities diabetes, end-stage renal disease, and non-
HIV immunosuppression were reported only from 2010–2012. In
subgroup analyses including these comorbidities, we transformed
traffic exposures into dichotomous rather than five-level categori-
cal variables as in the other analyses owing to the small number
of deaths in each subgroup. We evaluated the effects of nearest-
road traffic volumes on secondary outcomes including culture
conversion and successful treatment completion using unadjusted
Kaplan–Meier survival analyses and testing for statistical signifi-
cance between fifth- and first-quintile exposures using log-rank
tests. Statistical analyses were performed using Stata/SE 13.1
(StataCorp).
Results
Of 36,511 patients with active TB reported to the State of
California, we excluded 2,558 patients (7.0%) for whom we were
unable to perform geocoding and traffic linkage with street-level
accuracy (Figure 1). We excluded an additional 1,078 patients
(3.0%) who moved from California, died before treatment was
initiated, or for whom treatment records were incomplete. Our
final cohort of 32,875 patients with active TB contributed 22,576
person-years at risk {median follow-up of 224 d [interquartile
range (IQR) 184–293] per patient}. There were 2,305 deaths dur-
ing follow-up for a crude mortality rate of 1,021 deaths per
10,000 person-years. Most right-censored events were due to ei-
ther treatment completion or moving out of California, and only
2.8% were lost to follow-up or had unspecified outcomes. Sixty
percent of included patients were male, 44% were Asian, 38%
were Hispanic, 77% were foreign-born, and 5% were HIV-
infected (Table 1). Socioeconomic hardship was evident, with
53% unemployed, 5.8% homeless, and 13% using recreational
drugs, excess alcohol, or both within the year before enrollment.
Pulmonary TB was diagnosed in 80% of participants (24% of
these cases were cavitary), extrapulmonary TB was diagnosed in
29% of participants, and 79% of TB cases were microbiologically
confirmed. Patients living in high-traffic-density neighborhoods
were younger and more likely to be male, Asian, black, foreign-
born, a recent immigrant, from southern California or the San
Francisco Bay Area, living within the city limits, living in more
densely populated and lower-income block groups, unemployed,
homeless, a recreational drug/excess alcohol user, and HIV-
infected compared with those with low traffic density exposure.
A number of covariates were associated with increased mortality
during TB treatment in unadjusted analysis, including being
unemployed, having both pulmonary and extrapulmonary TB,
having TB meningitis, having miliary TB, having microbiologi-
cally confirmed TB, and having the following comorbidities: dia-
betes, HIV, non-HIV immunosuppression, and end-stage renal
disease (see Table S1).
Median (IQR) traffic volumes (vehicles/day) were 12,610
(5,000–24,800) vh/d at the nearest major road and 29,000
(17,600–45,000) vh/d at the highest-trafficked road in the 400-m
buffer (Table 2). Median (IQR) traffic densities (vehicles·kilome-
ter/hour) in the 100-to 400-m buffers were 106 (39.6–230), 356
(138–746), 820 (337–1,647), and 1,525 (690–3,009) vh·km/h,
respectively. In sensitivity analyses, excluded patients were simi-
lar to included patients with the following exceptions: Those
excluded were more likely to reside outside the city limits [257/
3,608 (7.1%) vs. 687/32,816 (2.09%)], in lower population den-
sity census block groups [mean± standard deviation (SD) 2,979±
4,656 persons=km2 vs. 5,672± 6,198 persons=km2], in less traffic-
dense neighborhoods [1,066± 2,724 vh  km=h in the 400-m
buffer vs. 2,977± 4,193 vh  km=h], in the Central Valley [800/
3,636 (22%) vs. 4,385/32,875 (13%)], and in higher income cen-
sus block groups [69,467± 35,039USD vs. 55,284± 28,847USD].
Figure 1. Study flow chart. TB, tuberculosis.
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Geocoding accuracy was slightly higher for patients enrolled
between 2010 and 2011 (geocoding score of 95± 14) than for those
enrolled in other years of the study (geocoding score of 93± 19;
p<0:001). Patients reported with TB between 2010 and 2011
were less likely to be excluded because of an inability to geo-
code the residential address [n=30=4,697 (0.63%)] than those
reported with TB in other years of the study [n=706=31,079
(2.2%)].
Traffic volumes and traffic densities were associated with
increased mortality during TB treatment, with statistically signifi-
cant p-trends for increasing HRs across quintiles for the majority
of the 12 scenarios tested (Table 3; see also Table S1). For
instance, participants exposed to the second quintile of nearest-
road traffic volumes within the 100-m buffer had a 3% increased
risk of death compared with those exposed to lowest-quintile traf-
fic volumes [HR=1:03 (95% CI: 0.86, 1.25)] (Figure 2). This
risk increased incrementally to a 28% risk of death for the highest
quintile of traffic volume exposure [HR=1:28 (95% CI: 1.07,
1.53)], a trend that was statistically significant (p-trend= 0:002)
(Figure 2). Furthermore, as the buffer size decreased, fifth-
quintile mortality hazards increased, and trends across quintiles
became more statistically significant. For example, although the
highest-trafficked road in the 400-m buffer was associated with
increased mortality, the fifth-quintile HR was only 1.10 (95% CI:
0.95, 1.27), and there was not a significant trend for increasing
mortality across quintiles. In contrast, fifth-quintile traffic vol-
umes of the highest-trafficked road in the 100-m buffer were
associated with a 29% increased hazard of death [HR=1:29
(95% CI: 1.07, 1.55)], with a significant trend across traffic expo-
sure quintiles (p-trend<0:001).
Among potential confounders, age and recent immigration
augmented mortality hazards, whereas sex, employment status,
HIV status, population density, and excess alcohol and/or recrea-
tional drug use attenuated mortality hazards. In alternative Cox
models, we adjusted for group-level covariates in addition to
individual-level covariates (Table 4) and found that the addition
of census block group household income did not attenuate HRs.
In contrast, adjusting for census-tract smoking estimates aug-
mented mortality hazards such that exposure to the highest quin-
tile (Q5) of nearest-road traffic volumes in the 100-m buffer was
associated with a 41% increased risk of death during TB treatment
[HR=1:41 (95% CI: 1.16, 1.75)] compared with lowest-quintile
(Q1) traffic volume exposures. In additional alternative Cox mod-
els, the findings did not change significantly with exclusion of
Table 1. Characteristics by traffic density, n=32,875.
Characteristic
Traffic density, n (%)a
Low (n=16,417)b High (n=16,458)b p-Value
Age at diagnosis, median (IQR), y 47.7 (30.8–64.5) 46.2 (30.5–62.2) <0:001
Male sex 9,570 (58.3) 10,012 (60.8) <0:001
Race and ethnicity <0:001
Asian 7,058 (43.0) 7,252 (44.1)
Hispanic 6,525 (39.8) 6,075 (36.9)
White, non-Hispanic 1,559 (9.50) 1,452 (8.82)
Black, non-Hispanic 1,100 (6.70) 1,508 (9.16)
Native American/Alaskan or Pacific Islander 144 (0.88) 137 (0.83)
Unknown 31 (0.19) 34 (0.21)
Foreign born 12,442/16,362 (76.0) 12,731/16,419 (77.5) 0.001
Recent immigrant 3,852/16,362 (23.5) 4,175/16,419 (25.4) <0:001
Region <0:001
Southern California 8,840 (53.9) 9,722 (59.1)
Central Valley 3,106 (18.9) 1,279 (7.77)
North Coast and Mountain 393 (2.39) 172 (1.05)
San Francisco Bay Area 3,159 (19.2) 4,760 (28.9)
Central Coast 919 (5.60) 525 (3.19)
Residence within the city limits 15,823/16,376 (96.6) 16,306/16,440 (99.2) <0:001
Population density, mean±SD, persons=km2c 4,196± 3,452 7,144± 7,779 <0:001
Median annual household income, median (IQR), USDc 53,832 (38,230–74,836) 45,722 (31,680–65,214) <0:001
Estimated census tract percent smoking prevalence, mean±SD 14:9± 5:11 14:1± 5:46 <0:001
Unemployed 8,124/15,824 (51.3) 8,680/16,082 (54.0) <0:001
Homeless 568/16,339 (3.48) 1,325/16,375 (8.09) <0:001
Substance abused 1,776/16,193 (11.0) 2,370/16,263 (14.6) <0:001
HIV-infected 648 (3.95) 985 (5.98) <0:001
Microbiologically confirmed TB 12,868/16,409 (78.4) 12,995/16,451 (79.0) 0.21
Pulmonary TB 13,050 (79.5) 13,146 (79.9) 0.39
Extrapulmonary TB 4,754 (29.0) 4,886 (29.7) 0.15
Cavitary TB 3,221/16,399 (19.6) 3,145/16,443 (19.1) 0.24
Miliary TB 279 (1.70) 287 (1.74) 0.76
MDR-TB 194/12,664 (1.53) 180/12,891 (1.40) 0.37
Treatment n=16,316 n=16,358 <0:001
Self-administered for all doses 2,857 (17.5) 3,020 (18.5)
DOT for all doses 8,856 (54.3) 10,145 (62.0)
DOT and self-administered doses 4,603 (28.2) 3,193 (19.5)
Days to culture conversion, median (IQR) 53 (32–78) 53 (33–80) 0.33
Treatment duration,e median (IQR), days 244 (188–301) 248 (190–302) 0.37
Note: DOT, directly observed tuberculosis (TB) treatment; IQR, interquartile range; MDR-TB, multidrug-resistant TB, resistant to both isoniazid and rifampicin; SD, standard devia-
tion; USD, U.S. dollars.
aTraffic density is defined as the sum of length-adjusted road segment traffic volumes in the 400-m buffer around residential addresses, using the median value of 1,525 vh km=h as
the low-high cutoff. Column values represent “Number (%)” unless indicated otherwise.
bThe denominator is 16,417 for low traffic density and 16,458 for high traffic density unless otherwise indicated.
cObtained from American Census Survey 2006-2010 census block group data (U.S. Census Bureau 2016).
dExcess alcohol and/or recreational drug use (oral, inhaled, or injected) within one year before TB diagnosis.
eTreatment duration among those who completed treatment.
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Table 2. Traffic statistics by buffer and quintile.
Exposure n Mean Median IQR Minimum Maximum
Traffic volumes of nearest
road (vh=24 h)
100-m buffer
Q1 3,866 2,077 2,082 1,210–2,830 32 3,900
Q2 3,815 6,087 5,960 4,940–7,290 3,906 8,680
Q3 3,865 12,242 12,000 10,245–14,100 8,686 16,500
Q4 3,815 21,283 21,314 18,700–23,650 16,521 26,500
Q5 3,830 54,292 35,056 30,000–45,000 26,508 382,000
All 19,191 19,160 12,000 4,940–23,600 32 382,000
200-m buffer
Q1 5,621 2,110 2,110 1,210–2,910 32 3,950
Q2 5,573 6,212 6,060 5,000–7,410 3,956 8,930
Q3 5,622 12,595 12,475 10,500–14,450 8,938 16,827
Q4 5,580 21,971 22,000 19,400–24,473 16,840 27,700
Q5 5,573 60,158 36,929 30,795–48,200 27,725 382,000
All 27,969 20,563 12,400 5,000–24,400 32 382,000
300-m buffer
Q1 6,212 2,119 2,130 1,210–2,920 32 3,960
Q2 6,246 6,249 6,100 5,000–7,500 3,961 9,000
Q3 6,246 12,785 12,646 10,700–14,700 9,010 17,000
Q4 6,157 22,227 22,285 19,700–24,700 17,004 27,879
Q5 6,201 61,321 37,208 31,000–49,275 27,887 382,000
All 31,062 20,898 12,600 5,000–24,700 32 382,000
400-m buffer
Q1 6,523 2,134 2,130 1,210–2,990 32 4,000
Q2 6,434 6,283 6,126 5,000–7,500 4,001 9,030
Q3 6,486 12,799 12,673 10,702–14,700 9,035 17,000
Q4 6,457 22,272 22,300 19,700–14,800 17,004 27,900
Q5 6,463 61,578 37,300 31,246–49,700 27,903 382,000
All 32,363 20,985 12,610 5,000–24,800 32 382,000
Traffic volumes of highest-
trafficked road (vh=24 h)
100-m buffer
Q1 3,912 2,682 2,600 1,481–3,860 32 5,000
Q2 3,821 8,080 7,960 6,470–9,610 5,020 11,500
Q3 3,856 15,748 15,700 13,600–17,700 11,530 20,300
Q4 3,951 25,099 24,789 22,600–27,740 20,301 30,300
Q5 3,758 74,191 41,853 35,000–61,000 30,358 382,000
All 19,298 24,876 15,700 6,390–27,500 32 382,000
200-m buffer
Q1 5,684 3,956 3,958 2,290–5,600 32 7,500
Q2 5,701 11,842 11,900 9,500–14,089 7,503 16,500
Q3 5,642 20,969 21,100 18,800–23,300 16,504 25,200
Q4 5,643 30,623 30,000 27,725–33,400 25,231 37,800
Q5 5,651 106,348 54,600 42,500–164,000 37,839 382,000
All 28,321 34,677 21,000 9,480–33,300 32 382,000
300-m buffer
Q1 6,286 5,633 5,500 3,260–8,000 32 10,809
Q2 6,322 16,253 16,400 13,666–18,841 10,810 21,300
Q3 6,332 25,612 25,600 23,450–27,700 21,303 29,865
Q4 6,260 35,908 35,540 32,356–39,400 29,892 44,004
Q5 6,308 138,578 124,000 52,718–210,000 44,012 382,000
All 31,508 44,410 25,600 13,700–39,400 32 382,000
400-m buffer
Q1 6,566 7,929 7,890 4,530–11,690 59 14,600
Q2 6,607 20,247 20,499 17,600–22,806 14,623 25,000
Q3 6,639 29,249 29,120 27,142–31,269 25,009 34,000
Q4 6,514 41,116 40,333 37,208–45,300 34,022 52,000
Q5 6,549 168,797 165,000 100,000–229,000 52,200 382,000
All 32,875 53,332 29,000 17,600–45,000 32 382,000
Traffic density (vh  km=h)
100-m buffer
Q1 3,861 15.3 14.8 8.33–14.8 0.008 30.6
Q2 3,860 51.1 49.8 39.6–62.7 30.6 74.8
Q3 3,878 107 106 88.8–125 74.8 146
Q4 3,852 204 200 172–230 146 276
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cases that were not microbiologically confirmed or with exclusion
of patients who lived at multiple addresses during treatment.
Region of residence, directly observed therapy, and census-
tract smoking prevalence modified the effects of traffic exposure
on mortality (Table 5). For instance, those exposed to the highest
quintile of traffic density in the 100-m buffer had an 88% increased
mortality hazard in the Central Valley and a 19% increased mortal-
ity hazard in southern California, but no increased hazard in the
San Francisco Bay Area (p-interaction= 0:03). Those who self-
administered some or all of their TB medication experienced an
increased traffic mortality hazard compared with those who
received only directly observed therapy, and traffic mortality
hazards were smaller for TB patients living in high-smoking cen-
sus tracts compared with those living in low-smoking census
tracts. Additionally, traffic effects were slightly higher in most buf-
fers for patients >65 y old, in patients enrolled from 2004–2009,
and in patients with diabetes (Table 5; see also Table S2); traffic
effects were slightly lower for those with HIV and other forms of
immunosuppression, but these interactions did not reach statistical
significance except for other forms of immunosuppression in the
100-m buffer. We tested multidrug-resistant (MDR) TB and cavi-
tation as possible confounders. Although both types of TB were
associated with mortality (see Table S1), adjusting for these varia-
bles did not significantly change HRs in multivariable analyses
Table 2. (Continued.)
Exposure n Mean Median IQR Minimum Maximum
Q5 3,847 704 419 333–633 277 8,998
All 19,298 216 106 39.6–230 0.008 8,998
200-m buffer
Q1 5,656 51.4 50.6 26.5–75.4 0.004 104
Q2 5,675 175 173 138–211 104 256
Q3 5,689 361 356 305–413 256 477
Q4 5,659 657 646 553–749 477 905
Q5 5,642 2,594 1,496 1,109–3,335 905 22,020
All 28,321 766 356 138–746 0.004 22,020
300-m buffer
Q1 6,266 126 123 61.5–190 0.17 262
Q2 6,316 425 423 335–507 262 610
Q3 6,328 829 819 711–947 610 1,087
Q4 6,318 1,453 1,416 1,241–1,650 1,087 1,964
Q5 6,280 5,532 3,939 2,533–7,614 1,964 34,642
All 31,508 1,671 820 337–1,647 0.17 34,642
400-m buffer
Q1 6,547 266 263 127–402 0.09 542
Q2 6,578 837 827 687–988 542 1,159
Q3 6,590 1,533 1,522 1,334–1,729 1,160 1,954
Q4 6,581 2,649 2,547 2,233–3,008 1,955 3,759
Q5 6,579 9,590 8,226 5,098–12,449 3,760 48,305
All 32,875 2,977 1,525 690–3,009 0.09 48,305
Note: IQR, interquartile range; Q1–Q5, quintiles 1 through 5, where Q5 is the highest quintile of traffic exposure; vh, vehicle.
Table 3. Adjusted mortality hazard ratios (95% confidence intervals) for traffic metrics in 100–400-m buffers around residential addresses.
Exposure 100-m buffer 200-m buffer 300-m buffer 400-m buffer
Traffic volumes of nearest road (vh=24 h)
n 18,396 26,814 29,753 30,985
Q1 (HR) 1.00 1.00 1.00 1.00
Q2 [HR (95%CI)] 1.03 (0.86, 1.25) 1.02 (0.87, 1.18) 1.01 (0.87, 1.17) 0.99 (0.85, 1.14)
Q3 [HR (95%CI)] 1.14 (0.95, 1.37) 1.13 (0.98, 1.32) 1.12 (0.97, 1.29) 1.10 (0.96, 1.26)
Q4 [HR (95%CI)] 1.19 (0.99, 1.43) 1.19 (1.03, 1.39) 1.20 (1.04, 1.38) 1.15 (1.00, 1.33)
Q5 [HR (95%CI)] 1.28 (1.07, 1.53) 1.19 (1.02, 1.38) 1.15 (1.00, 1.33) 1.13 (0.98, 1.30)
p-Trend 0.002 0.004 0.006 0.01
Traffic volumes of highest-trafficked road (vh=24 h)
n 18,500 27,156 30,185 31,480
Q1 (HR) 1.00 1.00 1.00 1.00
Q2 [HR (95%CI)] 1.07 (0.88, 1.29) 1.22 (1.05, 1.42) 1.22 (1.06, 1.41) 1.21 (1.05, 1.40)
Q3 [HR (95%CI)] 1.29 (1.08, 1.55) 1.29 (1.10, 1.50) 1.30 (1.12, 1.50) 1.11 (0.96, 1.28)
Q4 [HR (95%CI)] 1.29 (1.07, 1.54) 1.32 (1.14, 1.54) 1.22 (1.05, 1.42) 1.14 (0.98, 1.32)
Q5 [HR (95%CI)] 1.29 (1.07, 1.55) 1.24 (1.06, 1.45) 1.15 (0.99, 1.34) 1.10 (0.95, 1.27)
p-Trend <0:001 0.005 0.10 0.46
Traffic density (vh  km=h)
n 18,500 27,156 30,185 31,480
Q1 (HR) 1.00 1.00 1.00 1.00
Q2 [HR (95%CI)] 1.02 (0.85, 1.23) 1.25 (1.08, 1.46) 1.11 (0.96, 1.29) 1.07 (0.93, 1.24)
Q3 [HR (95%CI)] 1.07 (0.89, 1.29) 1.25 (1.08, 1.46) 1.30 (1.12, 1.49) 1.23 (1.07, 1.42)
Q4 [HR (95%CI)] 1.33 (1.12, 1.59) 1.31 (1.13, 1.52) 1.17 (1.01, 1.36) 1.12 (0.97, 1.30)
Q5 [HR (95%CI)] 1.18 (0.98, 1.41) 1.17 (1.00, 1.37) 1.13 (0.97, 1.31) 1.06 (0.91, 1.23)
p-Trend 0.005 0.04 0.09 0.36
Note: CI, confidence interval; HR, hazard ratio; p-trend, the p-value for the trend across quintiles of traffic exposure. Q1-Q5, quintiles 1 through 5, where Q5 is the highest quintile of
traffic exposure; vh, vehicle. Adjusted for age, sex, race, ethnicity, foreign birth, recent immigration within 5 y before tuberculosis (TB) diagnosis, population density, region of resi-
dence, unemployment within 1 y before TB diagnosis, homeless within one year before TB diagnosis, excess alcohol and/or recreational drug use within one year before TB diagnosis,
and HIV infection.
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(see Table S4). In addition, we tested both variables as potential
effect modifiers in the association between traffic density and mor-
tality and did not find statistically significant interactions in any of
the buffers (see Table S5). In mediation analyses, the effects of
traffic exposure on mortality did not appear to be mediated through
TB severity. Although surrogates for TB severity (smear positiv-
ity, having both pulmonary and extrapulmonary TB, TB meningi-
tis, and miliary TB) were all significantly associated with
increased mortality (see Table S1), traffic exposures were not stat-
istically significantly associated with TB severity, and the addition
of TB severity variables into Cox models did not attenuate mortal-
ity HRs. We also evaluated diabetes and end-stage renal disease as
intermediaries on the causal pathway from TRAP exposure to
mortality during TB treatment and found that although each
comorbidity was associated with increased mortality (see Table
S1), we did not find a statistically significant association between
traffic density and increased risk for diabetes or end-stage renal
disease.
In Kaplan–Meier survival analyses, the median time to culture
conversion was 54 d (IQR, 32–83), and the median time to suc-
cessful completion of treatment was 256 d (IQR, 190–309); these
times did not differ significantly between lowest- and highest-
quintile nearest-road traffic volumes in the 100-m buffer (see
Table S3, Figure S1, and Figure S2). The 2-month culture con-
version rates were 56% overall, 55% for patients exposed to
lowest-quintile nearest-traffic volumes (in the 100-m buffer), and
57% for those exposed to highest-quintile traffic. The 9-month
successful treatment completion rates were 54% overall, 55% for
patients exposed to lowest-quintile traffic, and 53% for patients
living near the highest-quintile traffic volumes.
Discussion
To our knowledge, this is the first study to investigate the effects
of traffic proximity on mortality during active TB treatment in a
large, longitudinally followed patient cohort. We found that
patients residing in high-traffic neighborhoods in California were
at increased risk of death during TB treatment compared with
those residing in low-traffic neighborhoods; we also found that
there were statistically significant trends of increasing mortality
across increasing quintiles of traffic exposure. Our findings were
robust across several analytical models and after controlling for
multiple demographic, socioeconomic, and clinical variables.
Our findings are consistent with a growing body of evidence
linking traffic proximity and traffic-related air pollution with all-
cause, cardiopulmonary, and cancer mortality (Beelen et al.
2008b; Cesaroni et al. 2012, 2013; Hart et al. 2011; Jerrett et al.
Figure 2. Cumulative hazards of death by nearest-road traffic volume quin-
tiles in 100-m buffers around residential addresses. Adjusted for age, sex,
race, ethnicity, foreign birth, recent immigration within 5 y before tuberculo-
sis (TB) diagnosis, population density, unemployment within one year
before TB diagnosis, homelessness within one year before TB diagnosis,
excess alcohol and/or recreational drug use within one year before TB diag-
nosis, and HIV infection. CI, confidence interval; HR, hazard ratio.
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2005, 2013; Thurston et al. 2015). Our study expands this evi-
dence by focusing on a specific and potentially vulnerable cohort
of patients using individual-level exposure and outcome data.
Mortality during TB treatment remains high, as was evident in
our study cohort and throughout the world (de Meer and van
Geuns 1992; Fielder et al. 2002; Sterling et al. 2006). Although
many factors have been implicated in these poor TB patient out-
comes (Oursler et al. 2002), the effects of environmental factors
such as ambient air pollution have remained uncertain. Our find-
ings provide preliminary evidence that residential proximity to
traffic could be an important modifiable risk factor for poor
TB outcomes, and further studies investigating the effects of
specific traffic-related pollutants are needed to confirm these
observations.
Traffic effects were greatest and most statistically significant
in the smaller buffers around residential addresses. Our observa-
tions are consistent with roadside air quality monitoring studies,
which have found progressive decay of ambient pollutant concen-
trations down to background levels within 300–600 m, with the
rate of decay over distance from the road dependent on vegeta-
tion barriers, wind direction, and type of pollutant (Karner et al.
2010; Nayeb Yazdi et al. 2015; Zhu et al. 2002). However,
between-buffer comparisons should be made with caution in our
study. Low-traffic neighborhood roads were not measured in this
analysis and likely accounted for a larger proportion of missing
data in smaller buffers, thus leading to potential differential mis-
classification of exposure between buffers.
There was a statistically significant dose–response relation-
ship across many of the 12 exposure scenarios tested, as indicated
by p-trends<0:05. However, the traffic effect on mortality typi-
cally plateaued in the third or fourth quintile and often dropped
slightly in the fifth quintile. It is possible that the traffic effect on
mortality is not linear but rather plateaus with higher levels of ex-
posure. The fifth-quintile exposure level also encompassed a
much larger exposure range than the other levels (Table 2), and
this heterogeneity in exposure in the fifth quintile could have
affected the results for this group.
Several interactions were evident from our analyses. Traffic
effects were more pronounced in southern California and the
Central Valley, where the background air quality is the poorest in
the state (ALA 2016), and were also greater in patients living in
low-smoking-prevalence census tracts. Evidence of smoking
effect modification has been observed in several ambient air pol-
lution health effects cohort studies, with some studies reporting
augmented air pollution effects in smokers and others reporting
diminished effects (Beelen et al. 2008a, 2008b; Blount et al.
2013; Puett et al. 2014). To our knowledge, there have been no
studies examining the effect modification of smoking in the asso-
ciation between air pollution and TB outcomes, and more
research is needed in this area using individual-level data because
our smoking analysis was limited by aggregate smoking esti-
mates. Traffic mortality hazards were significantly lower in those
exclusively receiving DOT for the duration of their treatment
than in those who received at least some self-administered dos-
ing, suggesting that substandard adherence to therapy may accen-
tuate the effects of traffic exposures in patients with active TB.
We are unaware of other studies that have evaluated medication
adherence and air pollution interactions, and further research is
needed to corroborate these findings because air pollution and
medication adherence may both be important risk factors for poor
treatment outcomes among vulnerable groups with respiratory dis-
ease (Canino et al. 2006). Traffic effects were slightly higher in
those ≥65 y old and in those with diabetes, raising concern that
advanced age and certain chronic diseases could increase suscepti-
bility to the harmful effects of air pollution. Further research is
needed in these vulnerable populations.
Our observational study is hypothesis-generating for future
studies. Through what biologic mechanisms did TRAP contribute
Table 5. Adjusted mortality hazard ratios (95% confidence intervals) for highest quintile traffic density in each buffer, stratified by effect modifier.
Population n 100-m buffer [HR (95% CI)] 200-m buffer [HR (95% CI)] 300-m buffer [HR (95% CI)] 400-m buffer [HR (95% CI)]
Entire cohort 31,480 1.18 (0.98, 1.41)* 1.17 (1.00, 1.37)* 1.13 (0.97, 1.31) 1.06 (0.91, 1.23)
Region
San Francisco Bay Area 7,731 0.88 (0.61, 1.26) 0.99 (0.73, 1.36) 1.18 (0.87, 1.61) 0.93 (0.69, 1.25)
Central Valley 3,902 1.88 (1.09, 3.24)* 1.78 (1.12, 2.84)* 1.53 (1.02, 2.31) 1.27 (0.87, 1.87)
Southern California 17,935 1.19 (0.94, 1.50)* 1.13 (0.92, 1.39) 1.04 (0.85, 1.26) 1.07 (0.87, 1.30)
p-Interaction — 0.03 0.19 0.52 0.85
Exclusive DOT
No 13,098 1.21 (0.86, 1.70)* 1.35 (1.00, 1.82)* 1.47 (1.10, 1.96)* 1.39 (1.06, 1.83)*
Yes 18,207 1.12 (0.91, 1.40) 1.03 (0.86, 1.24) 0.93 (0.78, 1.12) 0.85 (0.71, 1.01)
p-Interaction — 0.21 0.29 0.01 0.005
Smoking prevalence
Low 12,861 1.38 (1.04, 1.84)* 1.48 (1.16, 1.89)* 1.41 (1.11, 1.79)* 1.28 (1.01, 1.62)*
High 12,241 1.14 (0.83, 1.55) 1.12 (0.86, 1.44) 1.03 (0.81, 1.31) 0.93 (0.73, 1.17)
p-Interaction — 0.40 0.003 0.08 0.32
Age, y
0–64 24,154 1.05 (0.77, 1.41) 1.11 (0.91, 1.53) 0.94 (0.73, 1.21) 0.87 (0.68, 1.11)
≥65 7,326 1.24 (0.98, 1.55)* 1.17 (0.96, 1.42) 1.19 (0.99, 1.43)* 1.14 (0.96, 1.37)
p-Interaction — 0.63 0.84 0.45 0.47
Enrollment Year
2000–2003 11,392 1.01 (0.77, 1.34) 1.04 (0.81, 1.33) 1.05 (0.83, 1.34) 0.98 (0.77, 1.24)
2004–2006 7,140 1.68 (1.14, 2.48)* 1.40 (1.01, 1.95)* 1.29 (0.94, 1.75) 1.01 (0.76, 1.36)
2007–2009 6,793 0.99 (0.67, 1.46) 1.31 (0.95, 1.82) 1.37 (0.99, 1.88) 1.35 (0.99, 1.85)
2010–2012 6,155 1.33 (0.83, 2.12) 1.05 (0.73, 1.50) 0.90 (0.65, 1.25) 1.00 (0.73, 1.38)
p-Interaction — 0.07 0.69 0.84 0.44
HIV
No 29,929 1.26 (1.04, 1.52)* 1.19 (1.01, 1.40)* 1.15 (0.98, 1.34)* 1.06 (0.91, 1.23)
Yes 1,551 0.60 (0.32, 1.14) 0.95 (0.55, 1.63) 0.88 (0.51, 1.51) 1.09 (0.59, 1.99)
p-Interaction — 0.053 0.31 0.51 0.74
Note: CI, confidence interval; DOT, directly observed tuberculosis (TB) treatment; HR, hazard ratio. Adjusted for age, sex, race, ethnicity, foreign birth, recent immigration within 5 y
before TB diagnosis, population density, region, unemployment 1 y before TB diagnosis, homeless within one year before TB diagnosis, excess alcohol and/or recreational drug use
within one year before TB diagnosis, and HIV infection. The HR represents the highest quintile traffic density compared with the lowest quintile traffic density in each effect modifier
level and buffer. *A statistically significant trend (p-trend<0:05) exists across quintiles.
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to mortality in patients undergoing TB treatment? It is possible
that exposure to TRAP has deleterious effects on immunologic
responses to Mtb, a theory supported by in vitro and animal stud-
ies. For instance, TB-infected rats chronically exposed to diesel
exhaust particles (DEP) carried a higher mycobacterial burden
than nonexposed controls (Hiramatsu et al. 2005), and Mtb-
stimulated human peripheral blood monocytes exposed to DEP
demonstrated suppression of key host antimycobacterial immune
responses (Sarkar et al. 2012).
Our study has several strengths. TB patients were followed
longitudinally with demographic, clinical, treatment, and mortal-
ity data collected prospectively by trained health care providers
at the time of clinic visits, decreasing the likelihood of recall bias
and reporting errors. This was a large cohort study focusing on a
specific disease process for the entire state of California, where
TB notification rates are estimated at >99% (Curtis et al. 2001),
limiting the risk for potential selection bias. Medical fees were
not a significant barrier to receipt of necessary TB care, which is
covered by private health insurance, Medi-Cal, and county
Department of Public Health programs, thereby also reducing
loss to follow-up secondary to inability to pay for treatment.
Our study also has several limitations. Exposures with time
dependency, namely traffic volumes, traffic density, and residen-
tial addresses, were assigned fixed measurement times and val-
ues, likely leading to exposure misclassification. For instance, we
calculated traffic volumes and traffic densities from 2004
Caltrans data, reflecting traffic conditions near the midpoint of
our study. This was a reasonable approach because spatial traffic
gradients tend to remain stable over time, with a relatively ho-
mogenous increase in traffic volumes as population increases
(Beelen et al. 2007, 2008a). Any exposure misclassification intro-
duced would likely be nondifferential, biasing results toward the
null. Indeed, traffic effects appeared to be smaller in patients en-
rolled before 2004 and after 2009, although this effect modifica-
tion did not reach statistical significance. Geocoding was not
performed concurrently with patient enrollment, but rather during
the analysis, using 2010–2011 geocoding reference data sets.
This difference in timing introduced slight inaccuracies in geo-
coding the addresses of patients enrolled before or after the refer-
ence period, but the overall accuracy of the match remained high
(score 93/100) with the exclusion of only 2% of TB patients
owing to an inability to geocode addresses. Traffic exposure esti-
mates were limited to residential addresses and did not account
for microenvironments such as household air pollution, indoor
and outdoor pollution at work or school locations, or commuting
patterns. We did not estimate exposures to specific traffic-related
air pollutants such as PM2:5, NO2, or ozone. Any misclassifica-
tions of exposure were likely randomly distributed, resulting in
an underestimate of true adverse effects of TRAP on TB treat-
ment outcomes. We only considered baseline home addresses
and did not exclude those who moved to different addresses
within California during follow-up. However, exclusion of mov-
ers in alternative Cox models did not alter mortality hazards.
Determining the hazards of traffic exposures on cause-specific
mortality would have been informative, but these data were not
available. The differences in baseline characteristics by traffic
density are likely a reflection of inherent socioeconomic differen-
ces present in those living in highly polluted areas rather than a
reflection of selection bias given the similarities in baseline char-
acteristics between those excluded and those included in the final
survival analyses. The California TB Registry provided a wealth
of covariates but no individual-level direct measures of poverty
or tobacco smoking. Poverty could contribute to poor outcomes
at multiple stages in the TB management cascade, from late pre-
sentation for diagnosis to lack of access to medical care for
comorbidities to increased exposure to other risk factors. To
address these limitations, in alternative models (Table 4), we
adjusted for census block group household income and census-
tract smoking prevalence, and we found that adjusting for group-
level smoking augmented the effects of traffic exposure on mor-
tality. However, to avoid misinterpretation of group-level data
that could give rise to the ecologic fallacy (Haneuse and Bartell
2011), we only employed aggregate data in alternative models.
Traffic data were not available for small local roads, which likely
led to an underestimation of traffic densities at residential
addresses and to the exclusion of patients who did not live near
major roads. Excluded patients were similar to those included
except for factors that appeared to be related to rural living, and
of the included patients, 98% lived within the city limits. As
such, our findings are not generalizable to TB patients living out-
side of towns and cities.
Conclusion
TB patients living in high-traffic neighborhoods were at increased
risk for mortality during treatment even after controlling for de-
mographic, socioeconomic, and clinical factors. Our findings sug-
gest that TB patients are susceptible to the adverse health effects
of traffic-related air pollution and that traffic exposure might be
an important modifiable risk factor for poor TB treatment out-
comes. These findings should be confirmed with additional stud-
ies to determine the effects of traffic-related pollutants, and of
traffic measures in other settings, on tuberculosis outcomes.
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